aTYR PHARMA (ATYR) Cash & Equivalents (2014 - 2026)
aTYR PHARMA's Cash & Equivalents came in at $16.16 million for Q2 2026, down 6.2% from $17.22 million a year earlier but up 61.5% from the prior quarter.
Powered by 
Analysis
aTYR PHARMA (ATYR) Cash & Equivalents (2014 - 2026) Analysis & Trends
At the end of FY2025, aTYR PHARMA's Cash & Equivalents was $10.74 million, down 2.8% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of -8.7% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $11.06 million in FY2024 (-51.0%), $22.54 million in FY2023 (+125.9%), $9.98 million in FY2022 (+327.3%) and $2.34 million in FY2021 (-86.2%).
- The five-year range for quarterly Cash & Equivalents is $2.34 million (Q4 2021) to $59.74 million (Q3 2021).
- Year-over-year, Cash & Equivalents has declined for four consecutive quarters, with growth averaging 14.1% over the last eight quarters.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q4 2022 (growth of 327.3%), and the weakest in Q4 2021 (a decline of 86.2%).
- Business Quant data shows ATYR's Cash & Equivalents at $10.01 million (Q1 2026), $10.74 million (Q4 2025) and $6.15 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | 976.00 Mn |
| 10 | aTYR PHARMA | 15.87 Mn | -276.95 Mn | - | 16.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.16 Mn |
| Mar 31, 2026 | 10.01 Mn |
| Dec 31, 2025 | 10.74 Mn |
| Sep 30, 2025 | 6.15 Mn |
| Jun 30, 2025 | 17.22 Mn |
| Mar 31, 2025 | 10.36 Mn |
| Dec 31, 2024 | 11.06 Mn |
| Sep 30, 2024 | 11.46 Mn |
| Jun 30, 2024 | 6.81 Mn |
| Mar 31, 2024 | 6.81 Mn |
| Dec 31, 2023 | 22.54 Mn |
| Sep 30, 2023 | 9.79 Mn |
| Jun 30, 2023 | 12.31 Mn |
| Mar 31, 2023 | 20.69 Mn |
| Dec 31, 2022 | 9.98 Mn |
| Sep 30, 2022 | 18.36 Mn |
| Jun 30, 2022 | 8.48 Mn |
| Mar 31, 2022 | 8.32 Mn |
| Dec 31, 2021 | 2.34 Mn |
| Sep 30, 2021 | 59.74 Mn |
API Access
aTYR PHARMA Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ATYR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ATYR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ATYR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();